Elevara Medicines
PrivateLast Round
Series A
Oct 21, 2025
Total Funding Raised
$70M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elevara Medicines operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in October 2025.
Elevara Medicines is a biopharmaceutical company developing novel therapeutics to treat rheumatoid arthritis and other chronic inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elevara Medicines Comparables
Compare Elevara Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astellas Pharma Inc. | 74% | |
| Revolo Biotherapeutics | 70% | |
| LAPIX Therapeutics | 69% |
For institutional investors. Book with your work email.
Elevara Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 21, 2025 | ||||
| Seed | Mar 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elevara Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Series A |
| Monograph Capital | Series A, Seed |
| Sofinnova Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 51% MoM.
- Apr 3, 2026
Monthly visitors grew 64% MoM, from 586 to 959.
For institutional investors. Book with your work email.
Elevara Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elevara Medicines's valuation, stock price, and market status.
Is Elevara Medicines a public or private company?
Elevara Medicines is a private company.
What is the current stock price of Elevara Medicines?
Elevara Medicines is a private company, so its shares have no public market price. Caplight tracks Elevara Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elevara Medicines worth (valuation)?
Valuation information for Elevara Medicines is not publicly available.
Can I buy Elevara Medicines stock?
Elevara Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elevara Medicines's last funding round?
Elevara Medicines's most recent funding round was Series A on October 21, 2025.
Who are the main investors in Elevara Medicines?
Key investors in Elevara Medicines include Forbion, Monograph Capital, Sofinnova Partners.
Will Elevara Medicines IPO soon?
No public IPO plans have been announced for Elevara Medicines.
How can I track Elevara Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Elevara Medicines's shares on secondary markets.